Document is current
Any future updates will be listed below
-
Authors
Blacker, S.
Horgan, K.
Cromwell, DA.
Boyle, JM.
Wang, L.
Withrow, DR.
Delon, C.
Dodwell, D.
Verrill, M.
Lemanska, A.
Pinder, SE.
Frampton, AE.
-
Funding
Funding for this research was provided by:
Association of Breast Surgery
- License Information
-
More Information
Article History
Received: 3 September 2025
Accepted: 23 October 2025
First Online: 13 February 2026
Competing interests
: Author M.V. reports receiving speaker honoraria from AstraZeneca, Exact Sciences, Gilead, Lilly, NewBridge, Novartis, and Roche; serving on advisory boards for AstraZeneca, Daiichi-Sankyo, Exact Sciences, Gilead, Lilly, Merck, NewBridge, Novartis, Pfizer, and Roche; receiving travel and conference sponsorship from AstraZeneca, Novartis, and Roche; holding shares in Bayer and Roche; and receiving institutional clinical trial support from AstraZeneca, Exact Sciences, Novartis, Pfizer, and Roche. Author L.W. declares sponsorship from the Association of Breast Surgery (ABS). The remaining authors declare no relevant conflicts of interest.
